Analyzing Phillips 66 Partners’ 2017 Growth Drivers
PSXP’s current short interest is on the high side compared to its average of ~1% since its inception in 2013.
As of January 11, 2017, DuPont traded at a one-year forward PE multiple of 20.00x compared to its peers Dow Chemical (DOW) and LyondellBasell (LYB).
Analysts’ consensus indicates a 12-month target price for DuPont at $78.10—a return potential of 5.5% from its closing price of $74.03 on January 11.
DuPont (DD) offers defined benefit plans to 80% of its employees across the world along with other long-term employee benefits.
DuPont’s (DD) stock price remained flat with a marginal gain of 0.6% from December 1, 2016, to January 11, 2017. DuPont has been trading sideways.
Of the 23 broker firms in Reuters’ survey, JNJ received “buy” ratings from ~39% of the firms, while ~61% of the firms rated the company a “hold.”
JNJ announced a quarterly cash dividend of $0.80 per share on January 3. This payment represents a dividend growth rate of 6.7% over the previous year.
JNJ posted better-than-expected 2Q16 earnings results on July 20, 2016. But its share price has fallen ~2% since October 18, 2016.
On January 3, DePuy Synthes, a subsidiary of Johnson & Johnson (JNJ), entered into an asset purchase and development agreement with Interventional Spine.
Johnson & Johnson (JNJ) has faced many litigations over the years, the most serious of which being its faulty hip replacement system lawsuits.
In 3Q16, Johnson & Johnson (JNJ) reported sales of $17.8 billion, representing a YoY (year-over-year) growth of ~4.2%.
On January 9, JNJ’s Medical Device division announced its Orthopedic Episode of Care Approach, a data-driven program that will accelerate value-based care.
On January 10, 2017, 18 brokerage companies were actively tracking 3M Company’s (MMM) stock. Among them, 44% of analysts recommended “buys” on the stock.
Currently, MMM is trading at a premium compared to HON and UTX. All three companies’ revenues have remained range-bound in the past three years.
3M (MMM) offers defined benefit plans to all its US employees and those outside the United States as a well. Overall, the company has 80 defined plans across 28 countries.
3M Company’s (MMM) stock rose 3.2% from the beginning of December 2016 to January 9, 2017. MMM’s stock is hovering near its 52-week high.
As of January 6, 2017, HON was trading at a one-year forward PE multiple of 16.5x as compared to its peer United Technologies (UTX), which is trading at a one-year forward PE multiple of 17.2x.
As of January 6, 2017, 22 brokerage firms were actively tracking Honeywell (HON) stock. 82% of these analysts recommended a “buy” for the stock.
Honeywell (HON) offers defined benefit plans that cover the majority of its employees and retirees in the United States and many other countries.
Honeywell (HON) stock rose 1.7% in December 2016. The company’s stock performance in December was muted compared to November’s returns of 3.9%.